Clinical Trial Update: Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

View source ↗

Summary

Long-term study update of fingolimod in multiple sclerosis from the FTY clinical program; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fingolimod (fingolimod)

Snippet

Sponsor: Novartis | Conditions: Multiple Sclerosis | Status: COMPLETED